BIOMAT Database Logo BIOMAT Database Logo

The biological and antineoplastic properties of three triazine-derivatives. 1951

B GOLDBERG, and E B SCHOENBACH

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D014227 Triazines Heterocyclic rings containing three nitrogen atoms, commonly in 1,2,4 or 1,3,5 or 2,4,6 formats. Some are used as HERBICIDES. Triazine,Benzotriazines

Related Publications

B GOLDBERG, and E B SCHOENBACH
[Carcinogenic properties of derivatives of symmetric triazine].
January 1970, Voprosy onkologii,
B GOLDBERG, and E B SCHOENBACH
Antitumor properties of selected 1,2,4-triazine derivatives.
January 1980, Archivum immunologiae et therapiae experimentalis,
B GOLDBERG, and E B SCHOENBACH
Synthesis and biological action of 5-oxo-1,2,4-triazine derivatives.
July 1999, Die Pharmazie,
B GOLDBERG, and E B SCHOENBACH
Synthesis and antineoplastic properties of 3'-deoxy-3'-fluoroketonucleoside derivatives. Correlations between structure and biological activity.
October 1993, Carbohydrate research,
B GOLDBERG, and E B SCHOENBACH
Synthesis and biological evaluation of symmetrical 2,4,6-trisubstituted 1,3,5-triazine derivatives.
January 2013, Chemical & pharmaceutical bulletin,
B GOLDBERG, and E B SCHOENBACH
Synthesis of some 1,2,4-triazine derivatives with potential biological activity.
March 1988, Die Pharmazie,
B GOLDBERG, and E B SCHOENBACH
Optimization of the pharmacokinetic properties of potent anti-trypanosomal triazine derivatives.
May 2018, European journal of medicinal chemistry,
B GOLDBERG, and E B SCHOENBACH
Three-parameter modeling of the soil sorption of acetanilide and triazine herbicide derivatives.
February 2014, Bulletin of environmental contamination and toxicology,
B GOLDBERG, and E B SCHOENBACH
Synthesis and photo-physical properties of fluorescent 1,3,5-triazine styryl derivatives.
December 2011, Chemistry Central journal,
B GOLDBERG, and E B SCHOENBACH
Design, synthesis and biological evaluation of novel anti-cytokine 1,2,4-triazine derivatives.
November 2013, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!